ThinkProgress Logo

Health

Santorum Calls Abortion Exceptions To Protect Health Of The Mother ‘Phony’

ThinkProgress filed this report from West Des Moines, Iowa.

Longshot GOP presidential hopeful and former Pennsylvania Sen. Rick Santorum stomped for votes in Iowa on Tuesday, trumpeting his “culture wars” message. A longtime anti-abortion activist, Santorum is selling himself as the leading social conservative in a crowded field. Yesterday in West Des Moines, he made an appearance at a “crisis pregnancy center” called Informed Choices that tries to talk women out of having abortions. Santorum said that he “separates [himself] from the rest of the pack” and criticized the other candidates for simply “checking the box” on anti-abortion issues.

When discussing his track record as a champion of the partial birth abortion ban, Santorum dismissed exceptions other senators wanted to carve out to protect the life and health of mothers, calling such exceptions “phony”:

SANTORUM: When I was leading the charge on partial birth abortion, several members came forward and said, “Why don’t we just ban all abortions?” Tom Daschle was one of them, if you remember. And Susan Collins, and others. They wanted a health exception, which of course is a phony exception which would make the ban ineffective.

Watch it:

Santorum’s complete lack of empathy for women who find themselves with life-threatening pregnancies is repugnant, but not altogether surprising. When the Senate took up the ban in the ’90s, the debate was focused not on banning an abortion method, but rather on what exceptions would be allowed under the new law. Senators led by Santorum “refused to allow an exception even to protect the woman from serious harm to her health,” while President Clinton refused to sign the bill without one.

Although there are any number of serious medical emergencies that might require a woman to terminate a pregnancy in her third trimester to protect her own health, Santorum and his allies “said that ‘health’ is nothing but a loophole for women who would abort a pregnancy to fit into a prom dress.” Back then, Santorum decried “the selfishness, the individual self-centeredness” of legislators who were concerned about the health of pregnant women. Judging by his latest remarks, he’s still holding a grudge.

NEWS FLASH

Planned Parenthood Of Indiana Receiving Record Amount Of Donations To Continue Operations | The Huffington Post’s Laura Bassett reports that “as a federal judge considers whether to block the implementation of a recently-passed law that defunds Planned Parenthood of Indiana,” the organization “has received an unprecedented amount of donations from nearly 1,200 donors across three continents.” “The donations totaled $116,000, and PPIN estimates that the money will allow it to continue providing medical services to its current Medicaid patients through June 20.”

Yglesias

Performance Pay For Drugmakers

You tend to find the most interesting political stories in business sections, since there’s less of a commitment to “balance” and more of an effort to explain what’s actually happening. So I really liked this piece by Naomi Kresge and Allison Connolly about new German legislation to introduce performance pay for pharmaceutical companies that want their medicines to be eligible for coverage:

AstraZeneca (AZN) recently set the price of its new Brilique blood thinner, which it hopes will become its next blockbuster drug, at €1.69 ($2.38) per pill in Germany. Whether it will be allowed to maintain that price in Europe’s largest drug market remains to be seen. The British drugmaker, insurers, and German regulators are bracing for a yearlong battle over the medicine’s value, the first test of a new pricing law in Europe’s biggest economy.

What makes the legislation so wrenching for Big Pharma is that drug companies previously needed to show only that a drug was safe and worked better than a placebo. Now the onus is on companies to prove not just that a drug works but that it is actually worth more than older therapies. If a drugmaker can’t convince German regulators that its compound has greater efficacy or additional benefits, then it cannot charge more than rival medicines already on the market.

Established institutions generally dislike any change to their existing compensation systems, because things are naturally run by people who are well-adapted to the current system. But this is a change that not only should save some money by reducing expenditures on bad drugs, it should also change the nature of the drugs that get into the pipeline over the long term. Right now companies have a lot of incentive to let marketing and intellectual property considerations drive R&D. If you can produce a new drug in a category full of generics, get the patent, and market it to health providers as “new” and “better,” then you’re in a position to make money whether or not it’s actually new or better. Patients tend to trust what doctors tell them (even if it’s totally wrong) and practicing medical doctors aren’t research scientists doing independent inquiries into whether these things really are new and better.

But if pharmaceutical companies actually make more money with drugs that are actually better than they do with drugs that they just market better, this changes incentives and research priorities. The question, as ever when trying to design incentive programs, is whether or not the people in charge of doing the assessment actually know what they’re doing and have a workable system in place.

NEWS FLASH

Santorum: What Distinguishes Me From Romney Is… Obamacare | Republicans are wasting no time in linking Mitt Romney’s Massachusetts health care reform to the Affordable Care Act. Former New York Mayor Rudy Giuliani now regularly trots out the accusation as he travels around the country, and the declared presidential contenders are not far behind. Asked what most distinguished him from Romney during yesterday’s appearance on Fox News’ Greta Van Susteren, Santorum pointed to… Obamacare. Watch it:

Why Blue Shield’s Decision To Cap Income Is So Significant

The Los Angeles Times has a more skeptical reading of why Blue Shield of California has chosen to voluntarily cap its net income and provide rebates to customers, arguing that the move is “richer in symbolism than in economic impact” and is “designed to deflect scrutiny and blame from insurers onto others in the industry, particularly doctors and hospitals”:

The point of the cap, Bodaken said, is to assure Blue Shield’s customers that its rate increases aren’t intended to fatten the company’s reserves. That’s true in an overall sense. The cap provides no guarantee, however, that Blue Shield is spending its premium dollars wisely — witness Bodaken’s $4.6 million salary, which is more than four times what the chief executive of his largest for-profit rival makes.

Nor does it give the company more incentive to hold down the rates it pays doctors and hospitals, whose cost increases can be passed on to consumers. As insurers have argued repeatedly, the main factor in rising premiums is treatment costs driven ever higher by increased demand for care and expensive new drugs and technologies.

All this sounds fair, and if Blue Shield’s actions can be used as an opportunity to go after provider rates or to pass legislation giving regulators greater authority to police premium increases, then it’s even more important than the LA Times is suggesting.

But this also strikes me as significant because rather than using the interim period between passage of the Affordable Care Act and when most of the insurance regulations are enacted in 2014 to increase profits and force the sickest (and costliest) beneficiaries off their rolls — as some companies are now doing — Blue Shield is actually getting ahead of the regulations by moving toward the goals of reform, not away from them. And that’s a good example for the health care industry as a whole.

NEWS FLASH

Three Reasons Why Ryan’s Medicare Plan Is Not Like Medicare Part D | Ezra Klein takes down Rep. Paul Ryan’s (R-WI) claim that his Medicare reform plan is just like the current Medicare Part D program. Klein identifies three problems: “The first is that it’s misleading on what’s driving cost growth in Part D. The second is that it’s misleading on how much cost growth there’s been in Part D. The third is that it’s misleading on how Ryan’s plan is structured.”

NEWS FLASH

What Is Driving Dems To Oppose The IPAB? | Politico’s Jen Haberkorn is reporting that the Republicans’ push to repeal the Independent Payment Advisory Board (IPAB) — a 15-member commission that would make recommendations to Congress about lowering Medicare spending if costs increase beyond a certain point — may be gaining some traction with Democrats. By our count, seven six Democrats now support repeal: Berkley (NV), Castor (FL), Capuano (MA), Kissell (NC), Linda Sanchez (CA), and Schwartz (PA). All received substantial amounts of money from the health care industry, which would be most affected by the board.

Update

We originally misreported that Rep. Pete Stark (D-CA) is a co-sponsor of the IPAB repeal bill. To be clear, Stark opposes IPAB, but does not support this particular legislative vehicle.

The Truth About Employers Dropping Health Insurance Coverage

Republicans have now seized on a new survey of employers which found that “at least 30 percent of companies say they will ‘definitely or probably’ stop offering employer-sponsored coverage” once a new ACA provision requiring businesses with workers receiving subsidies in the exchanges to pay a fee or offer coverage takes affect in 2014 and are using it to press their case against the new law:

- NEWT GINGRICH: “30%+ employers could eliminate coverage b/c Obamacarehttp://bit.ly/j1I3l8 So much for “if you like your coverage you can keep it”

- MICHELE BACHMANN: Will your employer be one of the 3 out of 10 employers who are likely to drop health coverage after #ObamaCare? http://tiny.cc/iq2qb #tcot

- JOHN BOEHNER: “As businesses begin planning for the onslaught of ObamaCare taxes, mandates, regulations, and penalties coming down the pike, many are left with two untenable choices: stop offering health care for their employees, or eliminate full-time jobs and keep wages low.”

I pointed out yesterday that this particular survey undermines other studies that have predicted that only a small number of employers would drop coverage, and suggested that if policymakers were truly interested in reducing the erosion of employer-sponsored coverage, then they should support adding an employer mandate to the Affordable Care Act.

But that aside, we’ve been seeing fluctuations in employer coverage rates long before the Affordable Care Act was enacted, as employers struggled with skyrocketing health care costs. Employer-sponsored health insurance “covered 58.9 percent of people under age 65 in 2009, down from 61.9 percent in 2008, and a total decline of 9.4 percentage points since 2000“:

The difference now is that we’ll probably see a much smaller drop, but any erosion will be matched by greater access — so that workers who lose their employer-sponsored coverage will actually have someplace to turn if their company decides to stop offering insurance. And of course those are the coverage options that Republicans are now seeking to repeal.

NEWS FLASH

Florida Says It Will Return $19 Million In Grants From The Affordable Care Act | Florida is one of the few states that is challenging the constitutionality of the Affordable Care Act to also return the federal grants it received from the law. The state has returned or refused to spend “at least $19 million in federal money” including: $1 million to help pay for a system that would allow consumers to monitor insurance rates, $2 million for hospice care for children, $8 million for construction of community health centers, a first installment on a five-year, $35.7 million grant to keep elderly and disabled people out of nursing homes by providing home health aides, and a federal grant that helped poor people get a break on their Medicare costs. Florida is “planning to accept $37 million” for the early retirement program, however.

Did The Health Reform Law Pressure Blue Shield Of California To Cap Its Profits?

Maggie Mahar makes the case for how the Affordable Care Act — particularly the provision requiring insurers to spend a certain percentage of premium dollars on health care costs — prompted Blue Shield of California to voluntarily cap its net earnings at 2 percent of revenue and issue $180 million in rebates to beneficiaries and providers:

Did “soul-searching” lead to this decision? Perhaps. But I would suggest that Blue Shield is responding, in an enlightened and pragmatic way to a climate change within the healthcare industry.

Government regulators are beginning to take a hard look at insurance premiums. Blue Shield California “had recently come under fire by state regulators for rate hikes,” ModernHealthcare.com explains. “In March, the company abandoned plans to raise rates on individual policyholders for the rest of the year, under pressure from the California Department of Insurance.”

Blue Shield is trying to inoculate itself against further criticism (and regulation) by getting ahead of the regulators. $180 million is hardly a huge sum. But pledging to put a 2 percent cap on net income is a serious step forward. This should help curb premium inflation– assuming that the company doesn’t fudge the way it calculates “net income.” Though now that Blue Shield has made a public commitment, I would guess that state regulators will keep an eye on that number.

Consumer advocates are undoubtedly hoping that Blue Shield’s move will pressure other nonprofit health care plans to begin issuing their own rebates, particularly as consumers are now using less care and insurer reserves are only increasing.

In a statement issued yesterday, HHS Secretary Kathleen Sebelius praised Blue Shield and seemed to attribute the rebates to pressure from the Affordable Care Act. “While such voluntary efforts are great for Blue Shield’s policyholders in California, today’s announcement also reinforces the importance of the Affordable Care Act and rigorous State review of insurance rates,” she said.

  • Comment Icon

The Morning CheckUp: June 8, 2011

Welcome to The Morning CheckUp, ThinkProgress Health’s 7:00 AM round-up of the latest in health policy and politics. Here is what we’re reading, what are you?

GOP targets tanning tax: “Rep. Michael Grimm (N.Y.) and 23 other Republicans have co-sponsored legislation to repeal the 10 percent tax included in last year’s healthcare overhaul.” [The Hill]

The case for denying patients the right to sue states over Medicaid cuts: “The remedy that is needed is a policy remedy—one that requires balancing interests and responsibilities of varied groups of citizens and multiple levels of government—and should be formulated, enacted, and overseen by policymakers, not the courts.” [Jim Hufford]

The big flaw in Paul Ryan’s Medicare videos: “Ryan and his video pretend that the R’s Medicare plan gives consumers the power to negotiate directly with health care providers, who can thus use their voucher-driven bargaining clout to hold down prices. But, in fact, that’s not how his plan works at all. Under his plan, seniors get to negotiate with insurance companies, not service providers (doctors, hospitals, etc.)” [Jared Bernstein]

Atlanta’s 11th Circuit will consider whether ACA coerces the states to expand Medicaid: and while the plaintiffs in the 26-state challenge to the law have some real complaints, they will have trouble convincing the Court. [Brad Joondeph]

A reminder that not all states oppose the law: “10 states and more than 150 state legislators — many of whom are from the 26 states that brought the lawsuit — have filed ‘friend of the court’ briefs supporting the constitutionality of the Act and arguing that it is good for their states and constituents.” [Huffington Post]

Pennsylvania to limit abortion coverage in health law: “The Pennsylvania state Senate is advancing a bill to ban abortion coverage from policies obtained through health insurance exchanges.” The measure now moves to the House. [AP]

Anti-choice activists in Tennessee pull an Indiana: Tennessee Right to Life is urging Governor Bill Haslam administration to deny more than $1 million in federal funds to the state’s Planned Parenthood chapters in Nashville and Memphis. [The Tennessean]

Berwick explains that he opposes premium support: because rather than improving care, such proposals “are about shifting burdens to states and individuals who already are struggling to do the best they can.” [Kaiser Health News]

Reducing hospital readmissions: “With one in five of its elderly hospital patients re-admitted within a month of discharge, the federal Medicare program plans next year to reduce how much it will pay hospitals for certain preventable re-admissions.” [WSJ]

NJ wants to cut its Medicaid program: it is one of 15 states seeking to make cuts this year or next. [NPR]

How states are containing Medicaid costs: “Provider payment cuts appear to be states’ most commonly proposed method to contain Medicaid costs in fiscal 2012, but a dozen states are also turning to increased provider taxes or fees to bring more money into the program.” In 2011, 10 states used provider taxes to generate more resources. [Inside Health Policy]

  • Comment Icon

Switch to Mobile
ThinkProgress Signup Overlay Skip and Continue to ThinkProgress Skip and Continue to ThinkProgress

Sign Up